BTO_0001948
stringlengths 11
11
| JURKAT E-6.1 cell
stringlengths 2
47
| Human, blood, leukemia, T cell line, clone E6.1.
stringlengths 20
1.28k
|
|---|---|---|
EFO_0022576
|
EC-9706
|
Human esophageal carcinoma cell line
|
EFO_0022577
|
D-270MG
|
Human glioblastoma cell line
|
EFO_0022578
|
G-292
|
Human osteosarcoma cell line
|
EFO_0022580
|
BL-41
|
Human Burkitt lymphoma cell line; established from the tumor tissue of an 8-year-old Caucasian boy with Burkitt lymphoma
|
EFO_0022583
|
SNU-251
|
Human ovarian endometrial cancer cell line
|
EFO_0022584
|
SACC-LM
|
Human salivary gland adenoid cystic carcinoma cell line
|
EFO_0022586
|
M249
|
Human melanoma cell line BRAF V600E mutation
|
EFO_0022587
|
HKB-11
|
Human somatic cell hybridoma (fused human embryonic kidney cells (293S) and modified Burkitt's lymphoma cells (2B8))
|
EFO_0022588
|
EUFA143
|
Human Fanconi anemia cell line
|
EFO_0022589
|
EUFA121
|
Human Fanconi anemia cell line
|
EFO_0022592
|
CAL-33
|
Human tongue squamous cell carcinoma established from the surgically removed fragment of a tongue lesion from a 69-year-old man with moderately differentiated squamous cell carcinoma of the tongue in 1983 (prior to therapy).
|
EFO_0022593
|
YTS-Eco
|
Human NK cell lymphoblastic leukemia/lymphoma cell line
|
EFO_0022594
|
HCN-1A
|
Human cortical neuronal cell line, established from a 18 months old female patient that suffered from unilateral megalencephaly.
|
EFO_0022595
|
PNT2
|
Human normal prostate epithelium cell line immortalized with SV40.
|
EFO_0022616
|
BD-215
|
Human Fanconi anemia cell line
|
EFO_0022617
|
MM200
|
Human melanoma cell line
|
EFO_0022618
|
MGR3
|
Human glioblastoma cell line
|
EFO_0022619
|
Rh-28
|
Human alveolar rhabdomyosarcoma cell line
|
EFO_0022620
|
CFBE41o-
|
Human Cystic fibrotic bronchial epithelial cell line
|
EFO_0022621
|
OECM-1
|
Human oral squamous cell carcinoma cell line
|
EFO_0022622
|
LCL 721.221
|
Human lymphoblastoid cell line
|
EFO_0022623
|
SOSP-9607
|
Human osteosarcoma cell line
|
EFO_0022625
|
ST-1
|
Human adult T cell lymphoma cell line
|
EFO_0022626
|
C666
|
Human nasopharyngeal carcinoma cell line
|
EFO_0022627
|
U-178MG
|
Human astrocytoma cell line
|
EFO_0022629
|
TPC-1
|
Human papillary thyroid carcinoma cell line
|
EFO_0022630
|
AC16
|
Human hybrid cardiomyocyte
|
EFO_0022632
|
2BS
|
Human transformed human fetal lung cell line
|
EFO_0022633
|
IHCF
|
Human immortalized corneal fibroblast
|
EFO_0022634
|
H157
|
Human oral squamous cell carcinoma cell line
|
EFO_0022635
|
PRIESS
|
EBV-transformed human lymphoblastoid cell line
|
EFO_0022636
|
FET
|
Human colorectal cancer cell line
|
EFO_0022637
|
T47D:A18
|
Human invasive breast carcinoma
|
EFO_0022638
|
SK-UT-2
|
Human endometrial carcinoma cell line
|
EFO_0022639
|
MO3.13
|
Human hybrid cell line that express phenotypic characteristics of primary oligodendrocytes
|
EFO_0022640
|
SAVC
|
Human B-lymphoblastoid cell line
|
EFO_0022641
|
BM9
|
Human B-lymphoblastoid cell line
|
EFO_0022642
|
PLH
|
Human B-lymphoblastoid cell line
|
EFO_0022643
|
BON-1
|
Human pancreatic neuroendocrine tumor cell line
|
EFO_0022644
|
PH5CH8
|
Human hepatocyte cell line
|
EFO_0022645
|
CWR-R1
|
Human prostate carcinoma cell line
|
EFO_0022646
|
HER911
|
Human embryonic retinoblasts
|
EFO_0022647
|
C-28/I2
|
Immortalized human chondrocyte cell line
|
EFO_0022648
|
253J-BV
|
Highly metastatic variant from human transitional cell carcinoma
|
EFO_0022649
|
KHYG-1
|
Human natural killer cell leukemia
|
EFO_0022650
|
UPCI-SCC-131
|
Human oral squamous cell carcinoma cell line
|
EFO_0022651
|
IHKE-1
|
Human immortalized kidney epithelial cell line
|
EFO_0022652
|
C3ABR
|
Human lymphoblastoid cell line
|
EFO_0022653
|
Hs-578Bst
|
Human breast epithelial cell line
|
EFO_0022654
|
MLS 2645-94
|
Human myxoid liposarcoma cell line
|
EFO_0022655
|
MLS 402-91
|
Human myxoid liposarcoma cell line
|
EFO_0022657
|
HOM-2
|
Human B-lymphoblastoid cell line
|
EFO_0022658
|
TE-1
|
Human esophageal squamous cell carcinoma cell line
|
EFO_0022659
|
EoL-1
|
Human eosinophilic leukaemia cell line
|
EFO_0022660
|
PITOUT
|
Human lymphoblastoid cell line
|
EFO_0022661
|
LCL1
|
Human lymphoblastoid cell line
|
EFO_0022662
|
OSU-2
|
Human fibroblast cell line
|
EFO_0022663
|
HuH-7-Lunet
|
Human hepatocellular carcinoma cell line
|
EFO_0022664
|
Colo-320
|
Human colorectal cancer cell line
|
EFO_0022665
|
SF-188
|
Human glioma cell line
|
EFO_0022667
|
RCB2099
|
immortal human esophagus-derived cell line
|
EFO_0022668
|
OVCAR-10
|
Human ovarian carcinoma cell line
|
EFO_0022669
|
8505C
|
Human cell line derived from thyroid cancer. Poorly differentiated papillary adenocarcinoma
|
EFO_0022670
|
UWR1
|
Human anaplastic astrocytoma cell line
|
EFO_0022671
|
UWR2
|
Human glioblastoma cell line
|
EFO_0022672
|
GES-1
|
Human normal gastric epithelial cell line
|
EFO_0022673
|
BHP5-16
|
Human amelanotic melanoma cell line
|
EFO_0022674
|
K1
|
Human thyroid gland papillary carcinoma cell line
|
EFO_0022675
|
NCI-H3122
|
immortal human lung-derived cell line
|
EFO_0022676
|
SW-1736
|
Human anaplastic thyroid cancer cell line
|
EFO_0022677
|
5-8F
|
High tumorigenic and metastatic subline of SUNE-1 cell line
|
EFO_0022678
|
HCCLM-3
|
Human hepatocellular carcinoma cell line
|
EFO_0022679
|
SACC-83
|
Human salivary gland adenoid cystic carcinoma
|
EFO_0022680
|
T2
|
Human-human somatic cell hybrid cell line, established by PEG-mediated fusion of the B-lymphoblastoid cell line LCL 721.174 with an 8-azaguanine and ouabain-resistant variant of the T-LCL CEM. Subclone of the T1 cell line which has lost both CEM(R)-derived copies of chromosome 6
|
EFO_0022681
|
SO-Rb50
|
Human retinoblastoma cell line
|
EFO_0022682
|
Flp-In-T-REx
|
T-REx cell derivative with targeted integration of a Flp-In expression vector
|
EFO_0022683
|
T-REx-HeLa
|
Human papillomavirus-related cervical adenocarcinoma
|
EFO_0022684
|
T/C-28a2
|
Human chondrocyte cell line
|
EFO_0022685
|
PER.C6
|
transformed human retinoblast cell line
|
EFO_0022686
|
HEK293S GnTI-
|
N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line
|
EFO_0022687
|
HuTu-80
|
Human duodenal adenocarcinoma cell line
|
EFO_0022688
|
LAN-5
|
Human neuroblastoma cell line
|
EFO_0022689
|
FU-OV-1
|
Human ovarian serous adenocarcinoma cell line
|
EFO_0022690
|
697
|
Human acute lymphoblastic leukemia cell line
|
EFO_0022691
|
BPH-1
|
Human benign prostate hyperplasia; prostate epithelial cells from a 68-year-old man with benign prostate hyperplasia; cells were immortalized with SV-40 large T-antigen; cells were described to express cytokeratins 8, 18, and 19 (but not 14) and to metabolize prostatic androgens
|
EFO_0022692
|
IMR-5
|
Human neuroblastoma cell line
|
EFO_0022693
|
HET-1A
|
Human esophageal cell line; derived in 1986 from human esophageal autopsy tissue by transfection with plasmid pRSV-T consisting of the RSV-LTR promoter and the sequence encoding the simian virus 40 large T-antigen
|
EFO_0022694
|
MOLM-13
|
Human acute myeloid leukemia cell line; established from the peripheral blood of a 20-year-old man with acute myeloid leukemia AML FAB M5a at relapse in 1995 after initial myelodysplastic syndromes
|
EFO_0022695
|
U6A
|
The 2fTGH-U6A Cell Line is part of a panel of IFNy pathway mutant fibrosarcoma cell lines isolated by chemical mutagenesis of IFNy insensitive reporter cells derived from HT1080 cells.
|
EFO_0022696
|
HVTs-SM1
|
Immortalized human vascular smooth muscle cells
|
EFO_0022697
|
tsA-201
|
A transformed human kidney 293 cell line stably expressing an SV40 temperature-sensitive T antigen
|
EFO_0022698
|
XPCS2BA
|
XPCS2BA; also has features of Cockayne syndrome; no evidence of malignancy; bilateral sensorineural hearing loss; dry skin; numerous freckles; hyperpigmented macules; broad-based choreoathetotic gait; brother of GM13025; donor subject is homozygous for a T>C transversion in the ERCC3 gene which results in a phenylalanine-99-to-serine missense mutation [PHE99SER (F99S)].
|
EFO_0022699
|
RAO-3
|
RAO-3 was established by transduction of the Q61L mutant RAS into human mammary epithelial cells that were immortalized with catalytic subunit of telomerase (hTERT)
|
EFO_0022700
|
EW-7
|
Human Ewing Sarcoma cell line
|
EFO_0022701
|
MCF-7/C4-12
|
Human invasive breast carcinoma
|
EFO_0022702
|
OV-2008
|
Human cystadenocarcinoma cell line
|
EFO_0022703
|
HSC-3
|
Human oral squamous cell carcinoma cell line
|
EFO_0022704
|
NCM-460
|
Nonmalignant human colonic epithelial cell line
|
EFO_0022705
|
U3118MG
|
Human glioblastoma cell line
|
EFO_0022706
|
U3082MG
|
Human glioblastoma cell line
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.